Table 2 Characteristics and correlation with sarcopenia in 89 patients undergoing radical cystectomy
Variables | Total cases, n (%) | Non-sarcopenia, n (%)† | Sarcopenia, n (%) † | P value ¶ |
|---|---|---|---|---|
Total cases | 89 (100%) | 67 (75%) | 22 (25%) | - |
Age at RC (year-old), median (IQR) | 71 (48–83) | 72 (66–75) | 71 (62–76) | 0.22 |
BMI (Kg/m2), median (IQR) | 22.7 (20.9–24.7) | 23.3 (21.6–24.75) | 21.8 (19.3–23.0) | 0.013 |
Sex | 0.16 | |||
Male | 70 (79%) | 55 (82%) | 15 (68%) | |
Female | 19 (21%) | 12 (18%) | 7 (32%) | |
ECOG-PS | 1.0 | |||
0 | 82 (92%) | 62 (93%) | 20 (91%) | |
≥ 1 | 7 (8%) | 5 (7%) | 2 (9%) | |
Clinical T category | 0.007 | |||
NMIBC | 6 (7%) | 2 (3%) | 4 (18%) | |
T2 | 42 (47%) | 36 (54%) | 6 (27%) | |
T3 | 19 (21%) | 16 (24%) | 3 (14%) | |
T4 | 22 (25%) | 13 (19%) | 9 (41%) | |
Clinical N category | 0.83 | |||
0 | 78 (88%) | 59 (88%) | 19 (86%) | |
≥ 1 | 11 (12%) | 8 (12%) | 3 (14%) | |
Variant histology | 0.21 | |||
No | 68 (76%) | 49 (73%) | 19 (86%) | |
Yes | 21 (24%) | 18 (27%) | 3 (14%) | |
Preoeprative nutrition index, median (IQR) | ||||
PNI | 47.0 (43.5–50.2) | 47.5 (44.0–51.0) | 45.2 (38.8–48.6) | 0.08 |
CONUT score | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.30 |
Preoeprative blood level, median (IQR) | ||||
Hb (g/dL) | 11.2 (10.2–12.7) | 11.6 (10.4–12.7) | 10.8 (9.8–12.1) | 0.07 |
CRP (mg/dL) | 0.2 (0.1–0.7) | 0.2 (0.1–0.6) | 0.4 (0.1–1.7) | 0.20 |
Albumin (g/dL) | 4.0 (3.7–4.2) | 4.0 (3.8–4.2) | 3.9 (3.6–4.2) | 0.47 |
Sodium (mEq/L) | 141 (139–143) | 141 (139–143) | 140 (138–143) | 0.09 |
LDH (U/L) | 180 (159–201) | 180 (159–201) | 181 (139–205) | 0.54 |
Neoadjuvant chemotherapy | 0.23 | |||
No | 52 (58%) | 38 (57%) | 14 (64%) | |
Yes | 37 (42%) | 29 (43%) | 8 (36%) | |
Adjuvant chemotherapy | 0.42 | |||
No | 75 (84%) | 56 (84%) | 19 (86%) | |
Yes | 14 (16%) | 11 (16%) | 3 (14%) | |